Terry Fry, MD
University of Colorado-Denver
Dr. Fry is a Professor of Pediatrics, Hematology and Immunology and Co-Director of the Human Immunology and Immunotherapy Initiative at the University of Colorado School of Medicine and holds the Robert and Kathleen Clark Endowed Chair in Pediatric Cancer Therapeutics at the Children’s Hospital Colorado. He arrived at Children’s Hospital Colorado in 2018 after serving as Head of the Hematologic Malignancies Section in the Pediatric Oncology Branch at the NIH where he led efforts in Cellular Immunotherapy for pediatric leukemia. Prior to the NIH, Dr. Fry was Chief of Blood and Marrow Transplantation at Children’s National Medical Center in Washington, DC. Dr. Fry’s research focuses on the preclinical and clinical development of chimeric antigen receptor T cells for pediatric cancers. He serves on the Committee for Scientific Affairs for the American Society of Hematology and was elected into the American Society for Clinical Investigation. Dr. Fry is also Senior Vice President and Head of T cell Therapeutics at Sana Biotechnology since 2019.